From precursor to reprogrammed cells: evolution of cardiomyoplasty

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue

Abstract

Myocardial infarction is underoxygenation-driven limited necrosis of heart tissues which results in elimination of ca. 0.5 to 1 billion spontaneously contracting cardiomyocytes (CM). Since the ability of human heart to regenerate is limited, efforts have been undertaken to increase the number of cardiomyocytes in post-infarction myocardium. Theoretically, such proposals might involve transplantation of 1) skeletal myoblasts and cardiomyocytes, or 2) progenitor/stem cells, theoretically capable of differentiating into cardiomyocytes, or 3) pluripotent cells such as embryonal stem cells (ESC) and induced pluripotent stem cells (iPSC) differentiating into cardiomyocytes. The efforts to increase CM could also involve 4) in situ reprogramming of fibroblasts into active cardiomyocyte-like cells, or 5) stimulating in situ proliferation of cardiomyocytes using pharmacological agents. Only three proposals merit closer scrutiny (2, 4 and 5). However, preclinical and clinical data have demonstrated weak ability of progenitor cells to differentiate (proposal 2). Nevertheless, transplanted cell-induced paracrine effects accompanying such therapy do improve functioning of the damaged heart muscle. The proposals that would permit the number of CM to be increased include in situ reprogramming of fibroblasts into active cardiomyocytes (proposal 4), as well as in situ stimulation of quiescent cardiomyocytes’ proliferation (proposal 5). It appears that an optimized therapeutic solution (increasing left ventricular ejection fraction and decreasing the post-infarct scar) might combine agents stimulating paracrine effects and reprogramming of fibroblasts.

Authors and Affiliations

Stanisław Szala, Sybilla Matuszczak, Justyna Czapla, Ewa Wiśniewska

Keywords

Related Articles

Insulinooporność a przewlekła reakcja zapalna

Insulinooporność jest stanem zmniejszonej odpowiedzi biologicznej tkanek na insulinę. Badania ostatnich lat spowodowały wzrost zainteresowania rolą przewlekłej reakcji zapalnej o niskiej aktywności w patogenezie insulino...

Perspectives on the pharmacotherapy of diseases extending with advanced oxidation protein products participation

In the view of constantly increasing number of reports about participation of advanced oxidation protein products (AOPPs) in pathogenesis of many diseases as well as in the pathomechanism of their biochemical disturbance...

Błony biologiczne. Molekularne terapie błon

Lipidy błonowe dzięki zróżnicowanej budowie cząsteczek, ładunkowi elektrycznemu i indywidualnym cechom biorą udział w bardzo wielu procesach cytofizjologicznych. Coraz dokładniejsze poznanie struktury błon biologicznych...

Pathophysiological consequences of hemolysis. Role of cell-free hemoglobin

Abundant hemolysis is associated with a number of inherent and acquired diseases including sickle-cell disease (SCD), polycythemia, paroxysmal nocturnal hemoglobinuria (PNH) and drug-induced hemolytic anemia. Despite dif...

Emergence of Pseudomonas aeruginosa with class 1 integron carrying blaVIM-2 and blaVIM-4 in the University Clinical Hospital of Bialystok (northeastern Poland)

The effectiveness of carbapenems, considered as last-resort antimicrobials in severe infections, becomes compromised by bacterial resistance. The production of metallo-β-lactamases (MBLs) is the most significant threat t...

Download PDF file
  • EP ID EP67287
  • DOI -
  • Views 132
  • Downloads 0

How To Cite

Stanisław Szala, Sybilla Matuszczak, Justyna Czapla, Ewa Wiśniewska (2014). From precursor to reprogrammed cells: evolution of cardiomyoplasty. Advances in Hygiene and Experimental Medicine, 68(), 153-161. https://europub.co.uk/articles/-A-67287